Assessment of Lipocalin 2, Clusterin, Soluble Tumor Necrosis Factor Receptor-1, Interleukin-6, Homocysteine, and Uric Acid Levels in Patients with Psoriasis
Table 1
Demographic and laboratory findings of psoriasis and healthy control groups.
Psoriasis
Control
56
33
Age
39.75 ± 18.29
36.18 ± 14.19
Male/female
21/35
11/22
PASI
8.3 ± 6.5
BMI (kg/m2)
26.7 ± 5.8
25.7 ± 5.1
Lipocalin 2 (ng/mL)
2.54 ± 0.46
**
2.07 ± 0.39
Clusterin (ng/mL)
2.55 ± 0.26
2.52 ± 0.18
sTNFR-1 (ng/mL)
0.33 ± 0.15
*
0.26 ± 0.06
IL-6 (pg/mL)
0.14 ± 0.3
0.13 ± 0.02
Homocysteine (mol/L)
13.55 ± 8.3
16.04 ± 9.3
Uric acid (mg/dL)
4.48 ± 1.2
4.20 ± 0.9
PASI: psoriasis area severity index; BMI: body mass index. ; .